A high-intensity functional exercise program for older people with dementia and living in residential care facilities (The Umeå Dementia and Exercise Study ? The UMDEX Study)

A high-intensity functional exercise program for older people with dementia and living in residential care facilities: a randomized controlled trial (The Umeå Dementia and Exercise Study ? The UMDEX Study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN31767087

Enrollment

183

Registered

2011-11-14

Start date

2011-08-29

Completion date

Unknown

Last updated

2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia disorders Mental and Behavioural Disorders Dementia

Interventions

Exercise intervention: The exercise intervention is based on the High-Intensity Functional Exercise Program (the HIFE Program). The program includes functional exercises consisting of everyday tasks c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosed dementia disorder and living in residential care facilities 2. Age 65 or over 3. Dependent on assistance from a person in one or more personal activities of daily living according to the Katz Index 4. Able to stand up from a chair with armrests with help from no more than one person 5. A Mini-Mental State Examination (MMSE) score of 10 or more 6. An approval from the resident?s physician 7. Able to hear sufficiently well to participate in the assessments 8. Able to understand Swedish language sufficiently well to participate in the assessments

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Dependence in personal activities of daily living (ADL) using the Functional Independence Measurement (FIM) and the Barthel ADL Index, at 4 (end of intervention period) and 7 months (follow-up 3 months after the intervention period), respectively.	—

Secondary

Measure	Time frame
1. Balance using Berg Balance Scale (BBS), at 4 and 7 months, respectively. 2. Mobility using self-paced timed walk (forward and backward, with and without ordinary walking aid if any) and the Chair-stand test, at 4 and 7 months, respectively 3. Cognitive functions using the Alzheimer?s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), verbal fluency, and Mini-Mental State Examination (MMSE), at 4 and 7 months, respectively. 4. Incidence of falls reported prospectively by staff and analysed at 6 and 12 months, respectively, from the end of intervention period. 5. Behaviour and psychological symptoms of dementia (BPSD) using the Neuropsychiatric Inventory (NPI) and delirium using the Organic Brain Syndrome (OBS) scale, at 4 and 7 months, respectively. 6. Attendance, adverse events and, for the exercise group, intensity achieved, using a structured report completed by the supervisors after each session. 7. Participants experiences of participating in the exercise, by an interview 8. Depressive symptoms using Geriatric Depression Scale (GDS-15) and Montgomery Åsberg Depression Rating Scale (MADRS), at 4 and 7 months, respectively. 9. Psychological wellbeing using Philadelphia Geriatric Centre Morale Scale (PGCMS) and experienced loneliness, at 4 and 7 months, respectively. 10. Mortality, diseases, and hospital admission, by reviewing participants? hospital records and death certificates for 12 months from the end of the intervention 11. Analyses of the levels of parathyroid hormone (PTH) and levels of vitamin D of the effect on ADL, falls, and physical and cognitive functions. 12. Explanatory analyses of the effect on ADL. Independent variables: FIM, Barthel ADL Index, MMSE, Mini Nutritional Assessment, BBS, depression, type of dementia disorder, drugs, age, sex, self-perceived health.	—

Measure

Time frame

1. Balance using Berg Balance Scale (BBS), at 4 and 7 months, respectively. 2. Mobility using self-paced timed walk (forward and backward, with and without ordinary walking aid if any) and the Chair-stand test, at 4 and 7 months, respectively 3. Cognitive functions using the Alzheimer?s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), verbal fluency, and Mini-Mental State Examination (MMSE), at 4 and 7 months, respectively. 4. Incidence of falls reported prospectively by staff and analysed at 6 and 12 months, respectively, from the end of intervention period. 5. Behaviour and psychological symptoms of dementia (BPSD) using the Neuropsychiatric Inventory (NPI) and delirium using the Organic Brain Syndrome (OBS) scale, at 4 and 7 months, respectively. 6. Attendance, adverse events and, for the exercise group, intensity achieved, using a structured report completed by the supervisors after each session. 7. Participants experiences of participating in the exercise, by an interview 8. Depressive symptoms using Geriatric Depression Scale (GDS-15) and Montgomery Åsberg Depression Rating Scale (MADRS), at 4 and 7 months, respectively. 9. Psychological wellbeing using Philadelphia Geriatric Centre Morale Scale (PGCMS) and experienced loneliness, at 4 and 7 months, respectively. 10. Mortality, diseases, and hospital admission, by reviewing participants? hospital records and death certificates for 12 months from the end of the intervention 11. Analyses of the levels of parathyroid hormone (PTH) and levels of vitamin D of the effect on ADL, falls, and physical and cognitive functions. 12. Explanatory analyses of the effect on ADL. Independent variables: FIM, Barthel ADL Index, MMSE, Mini Nutritional Assessment, BBS, depression, type of dementia disorder, drugs, age, sex, self-perceived health.

—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026